Mesirow Financial Investment Management Equity & Fixed Income Charles River Laboratories International, Inc. Transaction History

Mesirow Financial Investment Management Equity & Fixed Income

$97.3 Million
Q3 2024

1 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 08, 2022	BUY	$204.13 - $302.4 $1.58 Million - $2.34 Million	7,750 New	7,750 $1.66 Million

Others Institutions Holding CRL

# of Institutions

696

Shares Held

52.3M

Call Options Held

259K

Put Options Held

463K

Vanguard Group Inc Valley Forge, PA

6.1M
Shares

$1.22 Billion
0.02% of portfolio
Black Rock Inc. New York, NY

5.09M
Shares

$1.01 Billion
0.02% of portfolio
Wellington Management Group LLP Boston, MA

3.74M
Shares

$746 Million
0.13% of portfolio
State Street Corp Boston, MA

2.13M
Shares

$425 Million
0.02% of portfolio
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA

1.94M
Shares

$387 Million
0.87% of portfolio

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $10.1B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mesirow Financial Investment Management Equity & Fixed Income, based on Form 13F filings with the SEC.

News

Stay updated on Mesirow Financial Investment Management Equity & Fixed Income with notifications on news.

Account